215 related articles for article (PubMed ID: 10844079)
1. Treatment of optic nerve sheath meningioma with three-dimensional conformal radiation.
Moyer PD; Golnik KC; Breneman J
Am J Ophthalmol; 2000 May; 129(5):694-6. PubMed ID: 10844079
[TBL] [Abstract][Full Text] [Related]
2. Standard-fractionated radiotherapy for optic nerve sheath meningioma: visual outcome is predicted by mean eye dose.
Abouaf L; Girard N; Lefort T; D'hombres A; Tilikete C; Vighetto A; Mornex F
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1268-77. PubMed ID: 21640493
[TBL] [Abstract][Full Text] [Related]
3. Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma.
Arvold ND; Lessell S; Bussiere M; Beaudette K; Rizzo JF; Loeffler JS; Shih HA
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1166-72. PubMed ID: 19406585
[TBL] [Abstract][Full Text] [Related]
4. Optic nerve sheath meningioma: visual improvement during radiation treatment.
Vagefi MR; Larson DA; Horton JC
Am J Ophthalmol; 2006 Aug; 142(2):343-4. PubMed ID: 16876528
[TBL] [Abstract][Full Text] [Related]
5. Oncodiagnosis panel: 2002. Optic nerve glioma or optic nerve meningioma.
Brown PD; Wald JT; McDermott MW; Baumann GS; Cloughesy TF;
Radiographics; 2003; 23(6):1591-611. PubMed ID: 14635617
[No Abstract] [Full Text] [Related]
6. Efficacy of intensity-modulated radiation therapy for optic nerve sheath meningioma.
Sasano H; Shikishima K; Aoki M; Sakai T; Tsutsumi Y; Nakano T
Graefes Arch Clin Exp Ophthalmol; 2019 Oct; 257(10):2297-2306. PubMed ID: 31377848
[TBL] [Abstract][Full Text] [Related]
7. Long-term response to fractionated radiotherapy of presumed optic nerve sheath meningioma.
Lesser RL; Knisely JP; Wang SL; Yu JB; Kupersmith MJ
Br J Ophthalmol; 2010 May; 94(5):559-63. PubMed ID: 19965820
[TBL] [Abstract][Full Text] [Related]
8. The visual impact of fractionated stereotactic conformal radiotherapy on seven eyes with optic nerve sheath meningiomas.
Landert M; Baumert BG; Bosch MM; Lütolf UM; Landau K
J Neuroophthalmol; 2005 Jun; 25(2):86-91. PubMed ID: 15937428
[TBL] [Abstract][Full Text] [Related]
9. Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma.
Narayan S; Cornblath WT; Sandler HM; Elner V; Hayman JA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):537-43. PubMed ID: 12738331
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of fractionated conformal radiotherapy for the management of primary optic nerve sheath meningioma.
Pandit R; Paris L; Rudich DS; Lesser RL; Kupersmith MJ; Miller NR
Br J Ophthalmol; 2019 Oct; 103(10):1436-1440. PubMed ID: 30573496
[TBL] [Abstract][Full Text] [Related]
11. Improvement in visual function in an eye with a presumed optic nerve sheath meningioma after treatment with three-dimensional conformal radiation therapy.
Lee AG; Woo SY; Miller NR; Safran AB; Grant WH; Butler EB
J Neuroophthalmol; 1996 Dec; 16(4):247-51. PubMed ID: 8956159
[TBL] [Abstract][Full Text] [Related]
12. Total recovery of optic nerve sheath meningioma.
Charpentier P; Mouriaux F
BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27769976
[TBL] [Abstract][Full Text] [Related]
13. Optic nerve sheath meningiomas: visual improvement after stereotactic radiotherapy.
Liu JK; Forman S; Hershewe GL; Moorthy CR; Benzil DL
Neurosurgery; 2002 May; 50(5):950-5; discussion 955-7. PubMed ID: 11950397
[TBL] [Abstract][Full Text] [Related]
14. Fractionated stereotactic radiotherapy in patients with optic nerve sheath meningioma.
Paulsen F; Doerr S; Wilhelm H; Becker G; Bamberg M; Classen J
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):773-8. PubMed ID: 21300458
[TBL] [Abstract][Full Text] [Related]
15. Fractionated conformal radiotherapy for management of optic nerve sheath meningiomas: long-term outcomes of tumor control and visual function at a single institution.
Metellus P; Kapoor S; Kharkar S; Batra S; Jackson JF; Kleinberg L; Miller NR; Rigamonti D
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):185-92. PubMed ID: 20400241
[TBL] [Abstract][Full Text] [Related]
16. [Early symptoms and findings in optic nerve meningiomas].
Wilhelm H; Dörr S; Paulsen F; Becker G; Classen J
Klin Monbl Augenheilkd; 2009 Nov; 226(11):869-74. PubMed ID: 19916145
[TBL] [Abstract][Full Text] [Related]
17. A new approach to an old problem.
Fineman MS; Augsburger JJ
Surv Ophthalmol; 1999; 43(6):519-24. PubMed ID: 10416794
[TBL] [Abstract][Full Text] [Related]
18. Early improvements in vision after fractionated stereotactic radiotherapy for primary optic nerve sheath meningioma.
Baumert BG; Villà S; Studer G; Mirimanoff RO; Davis JB; Landau K; Ducrey N; Arruga J; Lambin P; Pica A
Radiother Oncol; 2004 Aug; 72(2):169-74. PubMed ID: 15297135
[TBL] [Abstract][Full Text] [Related]
19. Optimal management in optic nerve sheath meningioma - A multicentre study and pooled data analysis.
Ovens C; Dean B; Gzell C; Patanjali N; Jonker B; O'Connor M; Estoesta P; DeMartin T; Fraser C
J Clin Neurosci; 2020 Oct; 80():162-168. PubMed ID: 33099341
[TBL] [Abstract][Full Text] [Related]
20. Radiation retinopathy after fractionated stereotactic conformal radiotherapy for primary intraorbital optic nerve sheath meningioma.
Krishnan R; Kumar I; Kyle G; John Husband D
J Neuroophthalmol; 2007 Jun; 27(2):143-4. PubMed ID: 17549002
[No Abstract] [Full Text] [Related]
[Next] [New Search]
